Antimicrobial Treatment of Community-Acquired Pneumonia

Community-acquired pneumonia (CAP) is a clinical diagnosis that has a significant impact on health care management around the world. Early clinical suspicion and prompt empiric antimicrobial therapies are mandatory in patients with CAP. This article provides a review of recent studies and guidelines...

Descripción completa

Detalles Bibliográficos
Autores principales: Restrepo, Marcos I., Anzueto, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2005
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119139/
https://www.ncbi.nlm.nih.gov/pubmed/15802167
http://dx.doi.org/10.1016/j.ccm.2004.10.006
_version_ 1783514715661533184
author Restrepo, Marcos I.
Anzueto, Antonio
author_facet Restrepo, Marcos I.
Anzueto, Antonio
author_sort Restrepo, Marcos I.
collection PubMed
description Community-acquired pneumonia (CAP) is a clinical diagnosis that has a significant impact on health care management around the world. Early clinical suspicion and prompt empiric antimicrobial therapies are mandatory in patients with CAP. This article provides a review of recent studies and guidelines addressing antimicrobial therapy for hospitalized patients with CAP.
format Online
Article
Text
id pubmed-7119139
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71191392020-04-03 Antimicrobial Treatment of Community-Acquired Pneumonia Restrepo, Marcos I. Anzueto, Antonio Clin Chest Med Article Community-acquired pneumonia (CAP) is a clinical diagnosis that has a significant impact on health care management around the world. Early clinical suspicion and prompt empiric antimicrobial therapies are mandatory in patients with CAP. This article provides a review of recent studies and guidelines addressing antimicrobial therapy for hospitalized patients with CAP. Elsevier Inc. 2005-03 2005-03-28 /pmc/articles/PMC7119139/ /pubmed/15802167 http://dx.doi.org/10.1016/j.ccm.2004.10.006 Text en Copyright © 2005 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Restrepo, Marcos I.
Anzueto, Antonio
Antimicrobial Treatment of Community-Acquired Pneumonia
title Antimicrobial Treatment of Community-Acquired Pneumonia
title_full Antimicrobial Treatment of Community-Acquired Pneumonia
title_fullStr Antimicrobial Treatment of Community-Acquired Pneumonia
title_full_unstemmed Antimicrobial Treatment of Community-Acquired Pneumonia
title_short Antimicrobial Treatment of Community-Acquired Pneumonia
title_sort antimicrobial treatment of community-acquired pneumonia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119139/
https://www.ncbi.nlm.nih.gov/pubmed/15802167
http://dx.doi.org/10.1016/j.ccm.2004.10.006
work_keys_str_mv AT restrepomarcosi antimicrobialtreatmentofcommunityacquiredpneumonia
AT anzuetoantonio antimicrobialtreatmentofcommunityacquiredpneumonia

Ejemplares similares